A sole focus on computer simulation has been rejected by researchers, who say more basic research is needed before the brain can usefully be modelled in silico
The CEOs of Ablynx and uniQure, at a Science|Business event, tell their growth stories – and what Europe needs to do if there are to be more companies like theirs bringing new medicines to market
Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection
Winners of European Research Council Proof-of-Concept grants pitched their innovative ideas to investors and stakeholders at a Science|Business Innovation Board event last week.
Horizon 2020 is not only the EU’s biggest, broadest and most ambitious R&D initiative ever, it is the first to prioritise innovation. Now, company culture must respond, boosting the quality, pace and scale of innovation, says Joachim von Heimburg
Poland must break down the silos between academics and industry, to build the trust and infrastructures needed to underpin multilateral collaborations, and enable Polish medical researchers to capitalise on pharma’s thirst for external innovation
Lithuania has set a new research and innovation course - and it’s time to lift anchor, Dainius Pavalkis, Minister for Education and Science tells Science|Business
Spin-outs from four German and two UK universities feature among the nine finalists in the 2014 ACES Awards, along with universities from Denmark, Ireland and Switzerland.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.